A Whole Virion Vaccine for COVID-19 Produced Via a Novel Inactivation Method: Results from Animal Challenge Model Studies
I. K. Ragan, L. M. Hartson, T. S. Dutt, A. Obregon-Henao, R. M. Maison, P. Gordy, A. Fox, B. R. Karger, S. T. Cross, M. L. Kapuscinski, S. K. Cooper, B. K. Podell, M. D. Stenglein, R. A. Bowen, M. Henao-Tamayo, R. Goodrich
This paper evaluates a novel inactivated whole virion COVID-19 vaccine (SolaVAX) in hamsters, showing its ability to induce neutralizing antibodies and protect against SARS-CoV-2 infection.
bioRxiv · Nov 13, 2020Immunology